Now I finally understand it all. <G>
those dogs didn't invent that marking their territory thing without thinking it through very carefully
-----Original Message-----
From: marika <marika5
...@gmail.com>
Newsgroups: soc.culture.europe,soc.culture.usa,soc.culture.japan,soc.culture.australian ,alt.usenet.legends.lester-mosley
Date: Sunday, September 16, 2007 12:26 PM
Subject: Re: INTERNATIONAL STUFF - Global Success Highlights | Tax Law | R&D | Patents | Generics
>Frank Kalder wrote in message <1189941136.838101.70...@o80g2000hse.googlegroups.com>...
>marika wrote:
>> Frank Kalder - http://haplifnet.blogspot.com -
>. Global Success Highlights, Tax Law, R&D, and Patents
>> > [...]
>> I'll have to take a peek at the pdf later.
>Summary Report, page 7 (of 26):
>http://www.boehringer-ingelheim.com/corporate/download/ar/summaryrepo...
>> > Global business partition: 51% Americas, 31% Europe, 18% RoW.
>Global Activities: http://www.boehringer-ingelheim.com/corporate/asp/global/global.asp
>This family-owned corporation has currently almost 38,400 employees
>and 137 affiliated companies spread around the globe. ...
>> History: http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1.htm
>> Fascinating bio!
><<Indeed.
>You replied to the post which I had deleted because of a link error.
>That's why I've rearranged it (above); and repeated it at the
>Haplifnet with some supplements (at the bottom):
>http://groups.google.com/group/HAPLIF-GOVERNANCE/msg/5a26638d3772f849
>it is ok now, I wondered why you twice repeated the link to 2 mildy different subjects
>> > Shareholder's Perspective:
>> > "Family-owned companies such as ... are attracting
>> > considerable interest these days. As their strategy
>> > and investments are often directed towards ensuring
>> > the continuation of the company in the long term,
>> > family-owned companies have often proved to be particularly
>> > stable and crisis-resistant, especially in the volatile
>> > market conditions of recent years.
>> > The success of value-based family-owned companies is also
>> > confirmed by various surveys and indices comparing family-owned
>> > companies with listed ones. It is borne out by our own success
>> > as well.
>> Family owned or so called privately held Subchapter S corporations
>> have a special status in US tax law, making it clear that the US
>> desires to promote the continuation and success of such corporations.
>> Tax law is often used to create economic policy or to steer
>> it in certain directions.
>ACK.
>> > [...]
>> > We look forward to continuing to work closely with
>> > our employees, the Board of Managing Directors and
>> > the Advisory Board for the good of ... as a whole.
>> > Despite what is sometimes a difficult economic and
>> > political environment, and some highly competitive
>> > markets, we are confident that we are set to remain
>> > one of the world's leading pharmaceutical companies."
>> > http://www.boehringer-ingelheim.com/corporate/ar/shareholdersperspect...
><<Here's a photo of Christian Boehringer (42), Chairman
>of the Shareholders' Committee (as of January 2007):
>http://www.boehringer-ingelheim.com/corporate/ar/images/content/illu-...
>A very handsome man. I bet his leadership qualities are even better than his looks.
>> Interesting. One of the concerns of a typical pharmaceutical
>> these days is self styled ecoterrorists and the like.
>> The other bottom line one is controlling prices to the market
>> while continuing to perform research and development.
>> Natürlich icke weiß kein bout your patent and intellectual
>> property rights. In US it is about 21 years of exclusivity
>> after which if you don't replenish that property right with
>> another special formula your value on the market plummets.
>> Of course in the US, cost of complying with regulations and
>> dealing with lawsuits is another issue.
><<In Europe it is 20 years. However, the R&D and clinical tests of drugs
>require, thereof, about 10 to 12 years. And this is extremely cost-
>intensive and risky.
>"10 bis 12 Jahre durchschnittliche Entwicklungszeit eines Medikamentes
>von der Entdeckung des Wirkstoffes (=Patentierung) bis
>Markteinführung." http://www.fopi.at/data/media/1415.pdf (page 4 of
>23).
>Germany - a Pharma R&D "Standort"
>http://www.vfa.de/de/forschung/so-funktioniert-pharmaforschung/amf_st...
>that's quite a long pdf, I'm not sure I would have got to page 4 in technical language in one day, but when I get to a pdf equipped
>computer I'll take a stab. It's an interesting comparison.
>> "I stopped watching the cable news networks a couple of years
>> ago due to the ickyness and the general lack of news. However,
>> if there were such a thing as the Zombie Frank Zappa News Network,
>> you bet your ass I would resubsrcibe. --surferelf
><<Cute "icke" vs. "icky"!>>
>indeed ickyness in the news may here be dually interpreted as abundance of ego and self interest
>. O'zapft (Berlin)
>> > Another "schmunzl" story by Kerstin Jäckel (who stems from
>> > Rhineland-Palatinate):
>> > "O'zapft is - icke war da!"
>> > http://bunte.t-online.de/c/12/38/90/46/12389046.html
>> Berliners say "icke" instead of "ich" ("I").>>
>> Good ones~!
>> She resembles my realtor.
>Cute!
>> And she's got her mirndl dirndl on.
>:)
>> I guess Paris Hilton isn't doing any Oktoberfest hosting
>> in Germany this year.
>> I've noticed such regional differences in the pronunciation
>> of the sound ch across Germany.
>> I understand (unless someone is full of nonsense) that in
>> Vienna it's more like EEESSSH
><<In Austria and Bavaria, e.g., "ich" is just "i" (EEE).>>
>No kidding! I didn't notice when I was there.
>I guess everyone was actually speaking english anyway.
>Which reminds me that I was musing yesterday, that Bayer which makes aspirin must just mean Bavarian aspirin. Which I will have to
>take after too much Oktoberfizza
>. Connection
>> > A few days ago, I exchanged some information on a new joint
>> > venture etc with one of my buddies ...
>> Nice connection!
>. Generics & OTC
>> what do you mean by "generic corporation"?
><<I should have used the plural...
>Global corporations or smaller companies producing and selling
>generics (in German "Generika") and/or OTC products ('over the
>counter'), i.e. preparations imitating existing drugs, using patent-
>free agents.
>In addition: Generic names or chemical names of drugs; also, their
>official non-brand names, etc.>>
>generic brand drugs,
>I had to check
>because a generic corporation would have just meant the average corporation with lack of a distinguishing characteristic
>Fashion statement:
>I have heard twice this week that "the color" coming out of Paris is GREY GRAU GREY
>sounds boring
>mk5000
>"all I thought of was the cloven hooves and how they clip, clip, clop over the woven roofs"--aesop rock, bring back pluto
